Soros Fund Management LLC Has $20.77 Million Position in The Cooper Companies, Inc. (NASDAQ:COO)

Soros Fund Management LLC boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 29.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 225,930 shares of the medical device company's stock after acquiring an additional 50,930 shares during the period. Soros Fund Management LLC owned 0.11% of Cooper Companies worth $20,770,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of COO. T. Rowe Price Investment Management Inc. raised its holdings in Cooper Companies by 2.1% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company's stock valued at $705,928,000 after acquiring an additional 155,233 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Cooper Companies by 1.5% during the fourth quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company's stock worth $460,066,000 after buying an additional 74,501 shares in the last quarter. Geode Capital Management LLC increased its holdings in Cooper Companies by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company's stock valued at $449,907,000 after buying an additional 109,907 shares during the period. Victory Capital Management Inc. raised its stake in shares of Cooper Companies by 14.6% in the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after buying an additional 574,899 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its holdings in shares of Cooper Companies by 517.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock worth $324,466,000 after acquiring an additional 2,957,421 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Price Performance

Shares of COO traded up $1.16 during mid-day trading on Friday, hitting $82.30. 1,708,555 shares of the company traded hands, compared to its average volume of 1,430,222. The business has a 50-day moving average of $81.44 and a 200 day moving average of $91.91. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $16.46 billion, a price-to-earnings ratio of 42.21, a PEG ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. As a group, equities analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

COO has been the subject of several recent research reports. Citigroup dropped their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Piper Sandler reaffirmed an "overweight" rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Robert W. Baird dropped their price objective on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research note on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, Cooper Companies has a consensus rating of "Moderate Buy" and a consensus target price of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.